-
iShares Nasdaq Biotechnology (IBB) 30-day option implied volatility low, share price up 2.2%
-
iShares Nasdaq Biotechnology (IBB) call put ratio 1 call to 1.7 puts
-
FDA To Limit Industry Employees From Its Advisory Committees
-
iShares Nasdaq Biotechnology (IBB) call put ratio 1 call to 4.4 puts as share price down 2.4%
-
Increasing unusual option volume: PRGO FE ACHC IBB ALGM CRBG RC RSI EU ITW
-
iShares Nasdaq Biotechnology (IBB) spreader of 36K contracts of March 126 and March 127 puts
-
iShares Nasdaq Biotechnology (IBB) call put ratio 2.4 calls to 1 put into the annual J.P. Morgan Healthcare Conference
-
Altimmune (ALT) Added to Nasdaq Biotechnology Index
-
Increasing unusual put option volume: IBB BE SKX HTZ EH NKLA IW PLUG FVRR AES NXE
-
Increasing unusual put option volume: AGL CARR XLB WOOF SMMT PLCE CCI OWL IBB PLAY CNK
-
iShares Nasdaq Biotechnology (IBB) 35K contracts of October 135 puts trade
-
RBC's biotech survey shows investors more bearish vs. last time
-
Increasing unusual put volume: ITB IBB CMG CORZ BTBT GLW ACHR APLD

